Kangwon National University Hospital

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Kangwon National University Hospital
Short name
KNUH
Country, city
Republic of Korea, Chuncheon
Publications
1 473
Citations
20 842
h-index
61
Top-3 journals
Scientific Reports
Scientific Reports (63 publications)
PLoS ONE
PLoS ONE (37 publications)
Top-3 organizations
Top-3 foreign organizations
Harvard University
Harvard University (16 publications)
Brigham and Women's Hospital
Brigham and Women's Hospital (11 publications)

Most cited in 5 years

Ha E.J., Chung S.R., Na D.G., Ahn H.S., Chung J., Lee J.Y., Park J.S., Yoo R., Baek J.H., Baek S.M., Cho S.W., Choi Y.J., Hahn S.Y., Jung S.L., Kim J., et. al.
Korean Journal of Radiology scimago Q1 wos Q1 Open Access
2021-10-29 citations by CoLab: 148 Abstract  
Incidental thyroid nodules are commonly detected on ultrasonography (US). This has contributed to the rapidly rising incidence of low-risk papillary thyroid carcinoma over the last 20 years. The appropriate diagnosis and management of these patients is based on the risk factors related to the patients as well as the thyroid nodules. The Korean Society of Thyroid Radiology (KSThR) published consensus recommendations for US-based management of thyroid nodules in 2011 and revised them in 2016. These guidelines have been used as the standard guidelines in Korea. However, recent advances in the diagnosis and management of thyroid nodules have necessitated the revision of the original recommendations. The task force of the KSThR has revised the Korean Thyroid Imaging Reporting and Data System and recommendations for US lexicon, biopsy criteria, US criteria of extrathyroidal extension, optimal thyroid computed tomography protocol, and US follow-up of thyroid nodules before and after biopsy. The biopsy criteria were revised to reduce unnecessary biopsies for benign nodules while maintaining an appropriate sensitivity for the detection of malignant tumors in small (1-2 cm) thyroid nodules. The goal of these recommendations is to provide the optimal scientific evidence and expert opinion consensus regarding US-based diagnosis and management of thyroid nodules.
Kim J.H., Yoon H.J., Lee E., Kim I., Cha Y.K., Bak S.H.
Korean Journal of Radiology scimago Q1 wos Q1 Open Access
2021-01-01 citations by CoLab: 97 Abstract  
OBJECTIVE Iterative reconstruction degrades image quality. Thus, further advances in image reconstruction are necessary to overcome some limitations of this technique in low-dose computed tomography (LDCT) scan of the chest. Deep-learning image reconstruction (DLIR) is a new method used to reduce dose while maintaining image quality. The purposes of this study was to evaluate image quality and noise of LDCT scan images reconstructed with DLIR and compare with those of images reconstructed with the adaptive statistical iterative reconstruction-Veo at a level of 30% (ASiR-V 30%). MATERIALS AND METHODS This retrospective study included 58 patients who underwent LDCT scan for lung cancer screening. Datasets were reconstructed with ASiR-V 30% and DLIR at medium and high levels (DLIR-M and DLIR-H, respectively). The objective image signal and noise, which represented mean attenuation value and standard deviation in Hounsfield units for the lungs, mediastinum, liver, and background air, and subjective image contrast, image noise, and conspicuity of structures were evaluated. The differences between CT scan images subjected to ASiR-V 30%, DLIR-M, and DLIR-H were evaluated. RESULTS Based on the objective analysis, the image signals did not significantly differ among ASiR-V 30%, DLIR-M, and DLIR-H (p = 0.949, 0.737, 0.366, and 0.358 in the lungs, mediastinum, liver, and background air, respectively). However, the noise was significantly lower in DLIR-M and DLIR-H than in ASiR-V 30% (all p < 0.001). DLIR had higher signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) than ASiR-V 30% (p = 0.027, < 0.001, and < 0.001 in the SNR of the lungs, mediastinum, and liver, respectively; all p < 0.001 in the CNR). According to the subjective analysis, DLIR had higher image contrast and lower image noise than ASiR-V 30% (all p < 0.001). DLIR was superior to ASiR-V 30% in identifying the pulmonary arteries and veins, trachea and bronchi, lymph nodes, and pleura and pericardium (all p < 0.001). CONCLUSION DLIR significantly reduced the image noise in chest LDCT scan images compared with ASiR-V 30% while maintaining superior image quality.
Lee J.M., Kim H.K., Park K.H., Choo E.H., Kim C.J., Lee S.H., Kim M.C., Hong Y.J., Ahn S.G., Doh J., Lee S.Y., Park S.D., Lee H., Kang M.G., Koh J., et. al.
European Heart Journal scimago Q1 wos Q1
2022-12-20 citations by CoLab: 90 Abstract  
Abstract Aims In patients with acute myocardial infarction (MI) and multivessel coronary artery disease, percutaneous coronary intervention (PCI) of non-infarct-related artery reduces death or MI. However, whether selective PCI guided by fractional flow reserve (FFR) is superior to routine PCI guided by angiography alone is unclear. The current trial sought to compare FFR-guided PCI with angiography-guided PCI for non-infarct-related artery lesions among patients with acute MI and multivessel disease. Methods and results Patients with acute MI and multivessel coronary artery disease who had undergone successful PCI of the infarct-related artery were randomly assigned to either FFR-guided PCI (FFR ≤0.80) or angiography-guided PCI (diameter stenosis of &gt;50%) for non-infarct-related artery lesions. The primary end point was a composite of time to death, MI, or repeat revascularization. A total of 562 patients underwent randomization. Among them, 60.0% underwent immediate PCI for non-infarct-related artery lesions and 40.0% were treated by a staged procedure during the same hospitalization. PCI was performed for non-infarct-related artery in 64.1% in the FFR-guided PCI group and 97.1% in the angiography-guided PCI group, and resulted in significantly fewer stent used in the FFR-guided PCI group (2.2 ± 1.1 vs. 2.5 ± 0.9, P &lt; 0.001). At a median follow-up of 3.5 years (interquartile range: 2.7–4.1 years), the primary end point occurred in 18 patients of 284 patients in the FFR-guided PCI group and in 40 of 278 patients in the angiography-guided PCI group (7.4% vs. 19.7%; hazard ratio, 0.43; 95% confidence interval, 0.25–0.75; P = 0.003). The death occurred in five patients (2.1%) in the FFR-guided PCI group and in 16 patients (8.5%) in the angiography-guided PCI group; MI in seven (2.5%) and 21 (8.9%), respectively; and unplanned revascularization in 10 (4.3%) and 16 (9.0%), respectively. Conclusion In patients with acute MI and multivessel coronary artery disease, a strategy of selective PCI using FFR-guided decision-making was superior to a strategy of routine PCI based on angiographic diameter stenosis for treatment of non-infarct-related artery lesions regarding the risk of death, MI, or repeat revascularization.
Lkhagva E., Chung H., Hong J., Tang W.H., Lee S., Hong S., Lee S.
BMC Microbiology scimago Q2 wos Q2 Open Access
2021-02-12 citations by CoLab: 85 PDF Abstract  
The proliferation and survival of microbial organisms including intestinal microbes are determined by their surrounding environments. Contrary to popular myth, the nutritional and chemical compositions, water contents, O2 contents, temperatures, and pH in the gastrointestinal (GI) tract of a human are very different in a location-specific manner, implying heterogeneity of the microbial composition in a location-specific manner. We first investigated the environmental conditions at 6 different locations along the GI tract and feces of ten weeks’ old male SPF C57BL/6 mice. As previously known, the pH and water contents of the GI contents at the different locations of the GI tract were very different from each other in a location-specific manner, and none of which were not even similar to those of feces. After confirming the heterogeneous nature of the GI contents in specific locations and feces, we thoroughly analyzed the composition of the microbiome of the GI contents and feces. 16S rDNA-based metagenome sequencing on the GI contents and feces showed the presence of 13 different phyla. The abundance of Firmicutes gradually decreased from the stomach to feces while the abundance of Bacteroidetes gradually increased. The taxonomic α-diversities measured by ACE (Abundance-based Coverage Estimator) richness, Shannon diversity, and Fisher’s alpha all indicated that the diversities of gut microbiome at colon and cecum were much higher than that of feces. The diversities of microbiome compositions were lowest in jejunum and ileum while highest in cecum and colon. Interestingly, the diversities of the fecal microbiome were lower than those of the cecum and colon. Beta diversity analyses by NMDS plots, PCA, and unsupervised hierarchical clustering all showed that the microbiome compositions were very diverse in a location-specific manner. Direct comparison of the fecal microbiome with the microbiome of the whole GI tracts by α-and β-diversities showed that the fecal microbiome did not represent the microbiome of the whole GI tract. The fecal microbiome is different from the whole microbiome of the GI tract, contrary to a baseline assumption of contemporary microbiome research work.
Koo B., Hu X., Kang J., Zhang J., Jiang J., Hahn J., Nam C., Doh J., Lee B., Kim W., Huang J., Jiang F., Zhou H., Chen P., Tang L., et. al.
New England Journal of Medicine scimago Q1 wos Q1
2022-08-31 citations by CoLab: 83 Abstract  
In patients with coronary artery disease who are being evaluated for percutaneous coronary intervention (PCI), procedures can be guided by fractional flow reserve (FFR) or intravascular ultrasonography (IVUS) for decision making regarding revascularization and stent implantation. However, the differences in clinical outcomes when only one method is used for both purposes are unclear.We randomly assigned 1682 patients who were being evaluated for PCI for the treatment of intermediate stenosis (40 to 70% occlusion by visual estimation on coronary angiography) in a 1:1 ratio to undergo either an FFR-guided or IVUS-guided procedure. FFR or IVUS was to be used to determine whether to perform PCI and to assess PCI success. In the FFR group, PCI was to be performed if the FFR was 0.80 or less. In the IVUS group, the criteria for PCI were a minimal lumen area measuring either 3 mm2 or less or measuring 3 to 4 mm2 with a plaque burden of more than 70%. The primary outcome was a composite of death, myocardial infarction, or revascularization at 24 months after randomization. We tested the noninferiority of the FFR group as compared with the IVUS group (noninferiority margin, 2.5 percentage points).The frequency of PCI was 44.4% among patients in the FFR group and 65.3% among those in the IVUS group. At 24 months, a primary-outcome event had occurred in 8.1% of the patients in the FFR group and in 8.5% of those in the IVUS group (absolute difference, -0.4 percentage points; upper boundary of the one-sided 97.5% confidence interval, 2.2 percentage points; P = 0.01 for noninferiority). Patient-reported outcomes as reported on the Seattle Angina Questionnaire were similar in the two groups.In patients with intermediate stenosis who were being evaluated for PCI, FFR guidance was noninferior to IVUS guidance with respect to the composite primary outcome of death, myocardial infarction, or revascularization at 24 months. (Funded by Boston Scientific; FLAVOUR ClinicalTrials.gov number, NCT02673424.).
Ho T.T., Kim T., Kim W.J., Lee C.H., Chae K.J., Bak S.H., Kwon S.O., Jin G.Y., Park E., Choi S.
Scientific Reports scimago Q1 wos Q1 Open Access
2021-01-08 citations by CoLab: 64 PDF Abstract  
Chronic obstructive pulmonary disease (COPD) is a respiratory disorder involving abnormalities of lung parenchymal morphology with different severities. COPD is assessed by pulmonary-function tests and computed tomography-based approaches. We introduce a new classification method for COPD grouping based on deep learning and a parametric-response mapping (PRM) method. We extracted parenchymal functional variables of functional small airway disease percentage (fSAD%) and emphysema percentage (Emph%) with an image registration technique, being provided as input parameters of 3D convolutional neural network (CNN). The integrated 3D-CNN and PRM (3D-cPRM) achieved a classification accuracy of 89.3% and a sensitivity of 88.3% in five-fold cross-validation. The prediction accuracy of the proposed 3D-cPRM exceeded those of the 2D model and traditional 3D CNNs with the same neural network, and was comparable to that of 2D pretrained PRM models. We then applied a gradient-weighted class activation mapping (Grad-CAM) that highlights the key features in the CNN learning process. Most of the class-discriminative regions appeared in the upper and middle lobes of the lung, consistent with the regions of elevated fSAD% and Emph% in COPD subjects. The 3D-cPRM successfully represented the parenchymal abnormalities in COPD and matched the CT-based diagnosis of COPD.
Ali M., VandenBerg K., Williams L.J., Williams L.R., Abo M., Becker F., Bowen A., Brandenburg C., Breitenstein C., Bruehl S., Copland D.A., Cranfill T.B., Pietro-Bachmann M.D., Enderby P., Fillingham J., et. al.
Stroke scimago Q1 wos Q1
2021-03-15 citations by CoLab: 53 Abstract  
Background and Purpose: The factors associated with recovery of language domains after stroke remain uncertain. We described recovery of overall-language-ability, auditory comprehension, naming, and functional-communication across participants’ age, sex, and aphasia chronicity in a large, multilingual, international aphasia dataset. Methods: Individual participant data meta-analysis of systematically sourced aphasia datasets described overall-language ability using the Western Aphasia Battery Aphasia-Quotient; auditory comprehension by Aachen Aphasia Test (AAT) Token Test; naming by Boston Naming Test and functional-communication by AAT Spontaneous-Speech Communication subscale. Multivariable analyses regressed absolute score-changes from baseline across language domains onto covariates identified a priori in randomized controlled trials and all study types. Change-from-baseline scores were presented as estimates of means and 95% CIs. Heterogeneity was described using relative variance. Risk of bias was considered at dataset and meta-analysis level. Results: Assessments at baseline (median=43.6 weeks poststroke; interquartile range [4–165.1]) and first-follow-up (median=10 weeks from baseline; interquartile range [3–26]) were available for n=943 on overall-language ability, n=1056 on auditory comprehension, n=791 on naming and n=974 on functional-communication. Younger age (<55 years, +15.4 Western Aphasia Battery Aphasia-Quotient points [CI, 10.0–20.9], +6.1 correct on AAT Token Test [CI, 3.2–8.9]; +9.3 Boston Naming Test points [CI, 4.7–13.9]; +0.8 AAT Spontaneous-Speech Communication subscale points [CI, 0.5–1.0]) and enrollment <1 month post-onset (+19.1 Western Aphasia Battery Aphasia-Quotient points [CI, 13.9–24.4]; +5.3 correct on AAT Token Test [CI, 1.7–8.8]; +11.1 Boston Naming Test points [CI, 5.7–16.5]; and +1.1 AAT Spontaneous-Speech Communication subscale point [CI, 0.7–1.4]) conferred the greatest absolute change-from-baseline across each language domain. Improvements in language scores from baseline diminished with increasing age and aphasia chronicity. Data exhibited no significant statistical heterogeneity. Risk-of-bias was low to moderate-low. Conclusions: Earlier intervention for poststroke aphasia was crucial to maximize language recovery across a range of language domains, although recovery continued to be observed to a lesser extent beyond 6 months poststroke.
Sgueglia G.A., Lee B., Cho B., Babunashvili A., Lee J.B., Lee J., Schenke K., Lee S.Y., Harb S.
2021-04-20 citations by CoLab: 53 Abstract  
Among patients undergoing percutaneous coronary procedures, transradial access, compared with transfemoral access, is associated with a reduced risk for complications including mortality, especially in higher risk patients. However, transradial access is limited by radial artery occlusion (RAO) that despite being mostly asymptomatic because of the extensive anastomoses between the forearm arteries restricts future use of the same radial artery. Distal radial access (DRA) in the anatomic snuffbox or on the dorsum of the hand has recently gained global popularity as an alternative access route for vascular procedures. A strong anatomic and physiological rationale yields potential for significantly reduced risk for RAO and positive impact on procedural outcome for better patient care. Indeed, currently published studies buttress very low rates of RAO after DRA, hence supporting its development. The authors provide an analysis of the foundation of DRA, provide historical background, and offer a critical review of its current status and future directions. Also, given the limited evidence currently available to properly perform DRA in the real world, consensus opinion on what is considered optimal practice is also presented to supplement this document and enhance the implementation of DRA while minimizing its complications.
Finsterwalder S., Vlegels N., Gesierich B., Araque Caballero M.Á., Weaver N.A., Franzmeier N., Georgakis M.K., Konieczny M.J., Koek H.L., Karch C.M., Graff‐Radford N.R., Salloway S., Oh H., Allegri R.F., Chhatwal J.P., et. al.
Alzheimer's and Dementia scimago Q1 wos Q1
2020-08-18 citations by CoLab: 43
Lee U., Kim S., Shin J., Jeong C., Goh Y., Park M., Kwak J., Song S.Y., Cho B.
Scientific Reports scimago Q1 wos Q1 Open Access
2025-02-14 citations by CoLab: 0 PDF Abstract  
Radiation therapy is actively utilized for superficial lesions. External beam radiotherapy for cutaneous lesions utilizes electrons with low transmittance. Conventional electron beam therapy uses Cerrobend blocks for field shaping; however, the Intraoperative Radiotherapy (IORT) applicator offers superior dosimetric characteristics. The dosimetric parameters were measured using 4 and 6 MeV electron beams delivered by a Trilogy linear accelerator, and percent depth dose and lateral dose profiles were compared under the presence of the IORT applicator and Cerrobend block. The dose calculations under various IORT applicator conditions and planning studies were performed using Monte Carlo simulation. Treatment plans for three sites were evaluated in terms of coverage of the planning target volume, dose to the surrounding normal tissue, and beam-on time for two treatment modalities. The results of the measured and calculated dosimetric parameters correspond. Scattered electrons along the IORT applicators resulted in shorter dmax and R50 and sharper penumbras compared to the blocks. Oblique IORT applicators also maintained sharp penumbras. Treatment-plan analysis indicated significant reductions in normal tissue dose using the IORT applicator. Implementing IORT in clinical practice requires deliberation of extended beam-on times and associated patient safety protocols; however, the potential benefits regarding dose distribution warrant further optimization in clinical use.
Park S., Yi Y., Han S., Kim T., Kim S.J., Yoon Y.S., Kim S., Lee H.J., Heo Y.
Diagnostics scimago Q2 wos Q1 Open Access
2025-02-12 citations by CoLab: 0 PDF Abstract  
Background/Objectives: The methacholine bronchial provocation test (MBPT) is a diagnostic test frequently used to evaluate airway hyper-reactivity. MBPT is essential for diagnosing asthma; however, it can be time-consuming and resource-intensive. This study aimed to develop an artificial intelligence (AI) model to predict the MBPT results using forced expiratory volume in one second (FEV1) and bronchodilator test measurements from spirometry. Methods: a dataset of spirometry measurements, including Pre- and Post-bronchodilator FEV1, was used to train and validate the model. Results: Among the evaluated models, the multilayer perceptron (MLP) achieved the highest area under the curve (AUC) of 0.701 (95% CI: 0.676–0.725), accuracy of 0.758, and an F1-score of 0.853. Logistic regression (LR) and a support vector machine (SVM) demonstrated comparable performance with AUC values of 0.688, while random forest (RF) and extreme gradient boost (XGBoost) achieved slightly lower AUC values of 0.669 and 0.672, respectively. Feature importance analysis of the MLP model identified key contributing features, including Pre-FEF25–75 (%), Pre-FVC (L), Post FEV1/FVC, Change-FEV1 (L), and Change-FEF25–75 (%), providing insight into the interpretability and clinical applicability of the model. Conclusions: These results highlight the potential of the model to utilize readily available spirometry data, particularly FEV1 and bronchodilator responses, to accurately predict MBPT results. Our findings suggest that AI-based prediction can improve asthma diagnostic workflows by minimizing the reliance on MBPT and enabling faster and more accessible assessments.
Jang J., Lee S., Kim T., Lee E., Park S.W., Yeo N.Y., Kim Y.
Journal of Alzheimer's Disease scimago Q1 wos Q2
2025-02-09 citations by CoLab: 0 Abstract  
Background Hearing loss is a potentially modifiable risk factor implicated in dementia, with recent research suggesting an association between age-related hearing degradation and dementia. Objective This study aims to elucidate the relationship between hearing decline and dementia risk. Methods We analyzed data from 511,953 subjects from the Korean National Health Insurance Service-Senior Cohort (2002–2008). After excluding those diagnosed with dementia in 2002, 511,935 subjects were included. Subjects with hearing loss between 2002 and 2008 were selected and matched with a control group without hearing impairment based on age and gender. Statistical analyses, including Pearson's chi-squared test and the Cox proportional hazards model, were conducted, controlling for confounding variables such as household income and residential area. Subgroup analysis was also performed for Alzheimer's disease and vascular dementia. Results Subjects with hearing loss had a 1.245 times higher risk of all-cause dementia compared to those without hearing loss (adjusted hazard ratio over 3 years, 95% CI = 1.201–1.290), adjusting for gender, age, residence, and income. The adjusted hazard ratios for Alzheimer's disease over 3, 5, 7, and 10 years from the index date were 1.259 (95% CI = 1.211–1.308), 1.258 (95% CI = 1.208–1.310), 1.269 (95% CI = 1.215–1.325), and 1.235 (95% CI = 1.170–1.304), respectively. No significant association was found for vascular dementia, except for 3 years. Conclusions Hearing loss consistently increased the risk of all-cause dementia and Alzheimer's disease across timespans, suggesting a complex link between hearing loss and neurodegenerative diseases. These findings highlight the importance of early intervention and cognitive monitoring for individuals with hearing loss.
Jang H., Shin D., Yoo H., Zetterberg H., Blennow K., Gonzalez‐Ortiz F., Ashton N.J., Day T.A., Lee E.H., Yun J., Na D.L., Kim H.J., Kang S.H., Kim K.W., Kim S.E., et. al.
Alzheimer's and Dementia scimago Q1 wos Q1
2025-02-05 citations by CoLab: 0 Abstract  
AbstractINTRODUCTIONThis study aimed to investigate the differential roles of various plasma biomarkers in a stepwise diagnostic strategy for Alzheimer's disease (AD).METHODSA total of 2984 participants, including 666 cognitively unimpaired (CU), 2032 with Alzheimer's clinical syndrome (ACS), and 286 non‐ACS individuals, were recruited. Plasma amyloid beta (Aβ) 42/40, four phosphorylated tau (p‐tau) epitopes, glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) levels were measured using immunoassays.RESULTSNfL demonstrated fair to excellent accuracy in differentiating non‐ACS from CU groups (area under the curve [AUC], 0.79 to 0.94). p‐tau217 had the highest accuracy for identifying Aβ (AUC 0.94) and tau positron emission tomography status (AUC 0.91). In the ACS group, p‐tau217 was the strongest predictor of cognitive decline (p < .001).DISCUSSIONNfL may serve as a useful screening tool, while p‐tau217 is particularly valuable for confirming AD pathology and prognosis.Highlights Plasma NfL could screen for cognitive impairment. p‐tau217 reliably detects AD pathology, regardless of diagnosis. p‐tau217 and GFAP predict prognosis in ACS. Each plasma biomarker plays a distinct role in stepwise AD diagnostics.
Lee D., Lee K., Park D., Moon G., Park I., Jeong Y., Sung K., Choi H., Kim Y.
Applied Sciences (Switzerland) scimago Q2 wos Q2 Open Access
2025-02-03 citations by CoLab: 0 PDF Abstract  
The human facial bone is made up of many complex structures, which makes it challenging to accurately analyze fractures. To address this, we developed advanced image analysis software which segments and quantifies spaces between fractured bones in facial CT images at the pixel level. This study used 3D CT scans from 1766 patients who had facial bone fractures at a university hospital between 2014 and 2020. Our solution included a segmentation model which focuses on identifying the gaps created by facial bone fractures. However, training this model required costly pixel-level annotations. To overcome this, we used a stepwise annotation approach. First, clinical specialists marked the bounding boxes of fracture areas. Next, trained specialists created the initial pixel-level unrefined ground truth by referencing the bounding boxes. Finally, we created a refined ground truth to correct human errors, which helped improve the segmentation accuracy. Radiomics feature analysis confirmed that the refined dataset had more consistent patterns compared with the unrefined dataset, showing improved reliability. The segmentation model showed significant improvement in the Dice similarity coefficient, increasing from 0.33 with the unrefined ground truth to 0.67 with the refined ground truth. This research introduced a new method for segmenting spaces between fractured bones, allowing for precise pixel-level identification of fracture regions. The model also helped with quantitative severity assessment and enabled the creation of 3D volume renderings, which can be used in clinical settings to develop more accurate treatment plans and improve outcomes for patients with facial bone fractures.
Joo H.A., Kang B.C., Kim T.S., Kang W.S., Park H.J., Chung J.W., Ahn J.H.
Acta Oto-Laryngologica scimago Q2 wos Q3
2025-02-03 citations by CoLab: 0
Hwang G., Park C., Son S.J., Roh H.W., Hwang J.Y., Jang J., Jo Y.T., Byeon G., Youn H., Park R.W.
2025-02-01 citations by CoLab: 0 Abstract  
The association between delirium and dementia has been suggested, but mostly in the postoperative setting. This study aims to explore this relationship in a broader inpatient population, leveraging extensive real-world data to provide a more generalized understanding.
Baek S.W., Noh J.H., Lee D.
2025-02-01 citations by CoLab: 1 Abstract  
The purpose of this study is to assess the effectiveness of aromatherapy for postoperative nausea and vomiting (PONV) after total knee arthroplasty (TKA) under spinal anesthesia.
Kim K., Lee R., Park I., Hwang S., Kim Y., Jang J., Kim H., Choi S., Kim S.J., Cho H.J., Cho I., Kim J., Kim D., Nah S.
Biomolecules scimago Q1 wos Q1 Open Access
2025-01-26 citations by CoLab: 0 PDF Abstract  
Ginseng, a traditional herbal medicine with a long history of use, is known to support human health, particularly by influencing brain function. Recent studies have identified gintonin, a lysophosphatidic acid (LPA) receptor ligand derived from ginseng, as a key bioactive. However, the specific LPA receptor subtypes targeted by gintonin in the human brain to exert its anti-Alzheimer’s (AD) effects remain unclear. This study aimed to elucidate the LPA receptor subtype targeted by gintonin in the human cortex. Using a fluorescent gintonin conjugate, we investigated receptor binding in cortical samples from healthy individuals (n = 4) and AD patients (n = 4). Our results demonstrated that fluorescent gintonin selectively binds to human cortical neurons rather than glial cells and that gintonin-binding sites are co-localized with the LPA4 receptor subtype. Furthermore, the expression of LPA4 receptors was significantly reduced in the cortical neurons of AD patients. These results suggest that the LPA4 receptor may serve as a novel histopathological marker for AD and represent a promising therapeutic target for gintonin-based prevention and treatment strategies.
Jun H., Han J., Hong M., Fitriana F., Syahada J.H., Lee W., Mazigo E., Louis J.M., Nguyen V., Cha S.H., Chun W., Park W.S., Lee S.J., Na S., Lee S., et. al.
Molecules scimago Q1 wos Q2 Open Access
2025-01-17 citations by CoLab: 0 PDF Abstract  
This study investigates the antimalarial potential of extracts and compounds from various plants used in traditional Korean medicine, in response to the increasing resistance of Plasmodium falciparum to standard treatments such as chloroquine and artemisinin. The antimalarial activity screening was conducted on 151 extracts, identifying the top seven candidates, including Geranium thunbergii (50% ethanol and 100% methanol extract), Reynoutria japonica, Amomum villosum (hot water and 50% ethanol extract), Cinnamomum zeylanicum, and Platycodon grandiflorum. Among these, G. thunbergii was identified as the top priority for further analysis due to its high antimalarial activity and high yield of bioactive compounds. The plant extracts were fractionated using ethyl acetate, chloroform, and hot water, and their efficacy against P. falciparum was evaluated through IC50 determination and microscopic analysis. The compounds evaluated included ellagic acid, gallic acid, afzelin, quercetin, and protocatechuic acid. Among the tested compounds, ellagic acid showed the most potent antimalarial activity with an IC50 of 1.60 ± 0.09 µM, followed by gallic acid (39.43 ± 1.48 µM) and afzelin (52.77 ± 1.84 µM). In contrast, quercetin (116.8 ± 3.78 µM) and protocatechuic acid (1.23 ± 0.02 mM) exhibited minimal antimalarial effects. Giemsa staining was employed to visualize parasite morphology and confirmed that ellagic acid is effective in inhibiting growth at the late trophozoite stage. These findings suggest that ellagic acid could serve as a promising lead compound for developing a novel antimalarial agent. This study highlights the importance of exploring plant-based compounds as alternative strategies against drug-resistant malaria. Further investigation into the mechanisms underlying the antimalarial activity of these compounds is necessary to fully validate their therapeutic potential.
Heo Y., Kim J., Hong S., Kim W.J.
BMC Pulmonary Medicine scimago Q2 wos Q2 Open Access
2025-01-14 citations by CoLab: 0 PDF Abstract  
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Single-cell RNA sequencing (scRNA-seq) provides gene expression profiles at the single-cell level. Hence, we evaluated gene expression in the peripheral blood of patients with COPD. Peripheral blood samples from seven healthy controls and eight patients with COPD were obtained in this study. The 10X Genomics Chromium Instrument and cDNA synthesis kit were utilized to generate a barcoded cDNA library for single cell RNA-sequencing. We compared the scRNA-seq data between the COPD and control groups using computational analysis. Functional analyses were performed using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses. scRNA-seq was used to analyze the transcriptome of peripheral blood mononuclear cells from seven normal controls and eight patients with COPD. We found an increased number of monocyte/macrophages in the COPD group compared to the normal control group. Among the differentially expressed genes (DEGs) in monocyte/macrophages, we identified 15 upregulated genes (EGR1, NR4A1, CCL3, CXCL8, PTGS2, CD83, BCL2A1, SGK1, IL1B, BTG2, NFKBIZ, DUSP2, MAFB, PLAUR and CCL3L1) and 7 downregulated genes (FOLR3, RPS4Y1, HLA-DRB5, NAMPT, CD52, TMEM176A and TMEM176B) in the COPD group compared to the normal control group. Using scRNA-seq, we found differences in cell type distribution, especially in monocyte/ macrophages. Several upregulated and downregulated genes were found in the monocyte/macrophages of the COPD group.
Park Y., Kim W.J., Han S.S., Heo Y.J., Moon D.H., Kwon O., Lee M.G., Hong J.Y., Lee C.Y., Hwang Y.S., Kim S.K., Jo H.S.
Respiratory Care scimago Q2 wos Q2
2025-01-01 citations by CoLab: 0
Ahn J.H., Won M.
2024-12-30 citations by CoLab: 0 PDF Abstract  
Ischemia/reperfusion (IR) injury is a complex pathophysiological process in which the restoration of blood flow to ischemic tissue paradoxically exacerbates tissue damage and death [...]
Kim S., Kim I., Yuh W.T., Han S., Kim C., Ko Y.S., Cho W., Park S.B.
Scientific Reports scimago Q1 wos Q1 Open Access
2024-12-30 citations by CoLab: 0 PDF Abstract  
Vertebral collapse (VC) following osteoporotic vertebral compression fracture (OVCF) often requires aggressive treatment, necessitating an accurate prediction for early intervention. This study aimed to develop a predictive model leveraging deep neural networks to predict VC progression after OVCF using magnetic resonance imaging (MRI) and clinical data. Among 245 enrolled patients with acute OVCF, data from 200 patients were used for the development dataset, and data from 45 patients were used for the test dataset. To construct an accurate prediction model, we explored two backbone architectures: convolutional neural networks and vision transformers (ViTs), along with various pre-trained weights and fine-tuning methods. Through extensive experiments, we built our model by performing parameter-efficient fine-tuning of a ViT model pre-trained on a large-scale biomedical dataset. Attention rollouts indicated that the contours and internal features of the compressed vertebral body were critical in predicting VC with this model. To further improve the prediction performance of our model, we applied the augmented prediction strategy, which uses multiple MRI frames and achieves a significantly higher area under the curve (AUC). Our findings suggest that employing a biomedical foundation model fine-tuned using a parameter-efficient method, along with augmented prediction, can significantly enhance medical decisions.
Lee J.M., Lee S.H., Kim J.H., Kim T.S., Chang S.H., Kim S.H., Lee J.H., Kang C.D., Park J.M.
2024-12-25 citations by CoLab: 0

Since 2001

Total publications
1473
Total citations
20842
Citations per publication
14.15
Average publications per year
61.38
Average authors per publication
9.41
h-index
61
Metrics description

Top-30

Fields of science

50
100
150
200
250
300
350
General Medicine, 348, 23.63%
Neurology (clinical), 155, 10.52%
Surgery, 132, 8.96%
Cardiology and Cardiovascular Medicine, 125, 8.49%
Radiology, Nuclear Medicine and imaging, 113, 7.67%
Psychiatry and Mental health, 101, 6.86%
Multidisciplinary, 99, 6.72%
Geriatrics and Gerontology, 86, 5.84%
Oncology, 83, 5.63%
Cellular and Molecular Neuroscience, 68, 4.62%
Orthopedics and Sports Medicine, 59, 4.01%
Neurology, 57, 3.87%
Cancer Research, 53, 3.6%
Pulmonary and Respiratory Medicine, 53, 3.6%
Biochemistry, 51, 3.46%
Ophthalmology, 51, 3.46%
Health Policy, 47, 3.19%
Molecular Biology, 45, 3.05%
Epidemiology, 45, 3.05%
Pediatrics, Perinatology and Child Health, 41, 2.78%
General Neuroscience, 38, 2.58%
Developmental Neuroscience, 38, 2.58%
Pharmacology, 33, 2.24%
Infectious Diseases, 32, 2.17%
Immunology, 31, 2.1%
Gastroenterology, 31, 2.1%
Genetics, 30, 2.04%
Public Health, Environmental and Occupational Health, 30, 2.04%
Obstetrics and Gynecology, 30, 2.04%
Immunology and Allergy, 29, 1.97%
50
100
150
200
250
300
350

Journals

10
20
30
40
50
60
70
10
20
30
40
50
60
70

Publishers

50
100
150
200
250
300
50
100
150
200
250
300

With other organizations

50
100
150
200
250
300
350
50
100
150
200
250
300
350

With foreign organizations

2
4
6
8
10
12
14
16
2
4
6
8
10
12
14
16

With other countries

20
40
60
80
100
120
USA, 106, 7.2%
China, 43, 2.92%
Singapore, 19, 1.29%
Germany, 17, 1.15%
United Kingdom, 17, 1.15%
Japan, 16, 1.09%
Australia, 13, 0.88%
Mexico, 13, 0.88%
Netherlands, 12, 0.81%
India, 10, 0.68%
Italy, 10, 0.68%
Russia, 9, 0.61%
Canada, 9, 0.61%
Spain, 8, 0.54%
Norway, 8, 0.54%
Brazil, 7, 0.48%
Sweden, 7, 0.48%
France, 6, 0.41%
Greece, 6, 0.41%
Vietnam, 4, 0.27%
UAE, 4, 0.27%
Philippines, 4, 0.27%
Finland, 4, 0.27%
Croatia, 4, 0.27%
Switzerland, 4, 0.27%
Portugal, 3, 0.2%
Egypt, 3, 0.2%
Indonesia, 3, 0.2%
Iran, 3, 0.2%
20
40
60
80
100
120
  • We do not take into account publications without a DOI.
  • Statistics recalculated daily.
  • Publications published earlier than 2001 are ignored in the statistics.
  • The horizontal charts show the 30 top positions.
  • Journals quartiles values are relevant at the moment.